SCIENTURE HOLDINGS, INC. Payments of Stock Issuance Costs
SCIENTURE HOLDINGS, INC. (SCNX) reported Payments of Stock Issuance Costs of $732.36 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2022-03-28
- SCIENTURE HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2020-12-31 was $1.00.
- SCIENTURE HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2020-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2020-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2020-03-31 was $732.36K.
- SCIENTURE HOLDINGS, INC. payments of stock issuance costs for fiscal 2020 was $732.36K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2020-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $1.00 derived: sum of 2 quarters · filed 2022-03-28 | $1.00 derived: sum of 3 quarters · filed 2022-03-28 | $732.36K 10-K · filed 2022-03-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-25 | $0.00 derived: sum of 2 quarters · filed 2021-10-25 | $732.36K 10-Q · filed 2021-10-25 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26 | $732.36K 10-Q · filed 2021-07-26 | ||
| 2020-03-31 | $732.36K 10-Q · filed 2021-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |